BioRestorative Therapies (BRTX)
BioRestorative Therapies on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders and insider trades. Listed on Nasdaq, classified by the SEC as services-misc health & allied services, nec.
13K
Short interest
settlement 2026-09-30
1.0
Days to cover
unchanged vs prior
52.9%
Short share of volume
2026-10-23
553
Fails to deliver
settlement 2026-09-30
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in BRTX is 13,152 shares, down 24,489 shares over the last month. Over the last 48 readings it ranged from 11,586 shares (15 September 2026) to 6,588,718 shares (29 May 2026). The latest reading sits at the bottom of that range. At the reported average volume of 33K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/brtx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 13,152 | +13.5% | 33,071 | 1.00 |
| 2026-09-15 | 11,586 | -69.2% | 40,553 | 1.00 |
| 2026-08-31 | 37,641 | -62.2% | 175,579 | 1.00 |
| 2026-08-14 | 99,687 | -78.5% | 298,477 | 1.00 |
| 2026-07-31 | 463,966 | -39.9% | 430,028 | 1.08 |
| 2026-07-15 | 772,008 | -30.2% | 294,295 | 2.62 |
| 2026-06-30 | 1,105,447 | -13.7% | 582,768 | 1.90 |
| 2026-06-15 | 1,281,247 | -80.5% | 1,895,030 | 1.00 |
| 2026-05-29 | 6,588,718 | +1687.2% | 65,163,071 | 1.00 |
| 2026-05-15 | 368,665 | -42.8% | 1,050,694 | 1.00 |
| 2026-04-30 | 644,870 | -0.3% | 1,170,480 | 1.00 |
| 2026-04-15 | 647,105 | -27.4% | 1,526,905 | 1.00 |
| 2026-03-31 | 890,908 | -32.4% | 3,378,307 | 1.00 |
| 2026-03-13 | 1,318,064 | +67.5% | 18,854,732 | 1.00 |
| 2026-02-27 | 787,086 | -35.8% | 18,567,889 | 1.00 |
| 2026-02-13 | 1,226,671 | +826.1% | 6,360,187 | 1.00 |
| 2026-01-30 | 132,462 | -0.0% | 21,039 | 6.30 |
| 2026-01-15 | 132,508 | -2.8% | 24,656 | 5.37 |
| 2025-12-31 | 136,274 | +9.7% | 40,544 | 3.36 |
| 2025-12-15 | 124,251 | +20.1% | 31,015 | 4.01 |
| 2025-11-28 | 103,490 | -27.4% | 137,880 | 1.00 |
| 2025-11-14 | 142,622 | +3.2% | 28,470 | 5.01 |
| 2025-10-31 | 138,174 | +10.8% | 472,599 | 1.00 |
| 2025-10-15 | 124,671 | +9.7% | 90,709 | 1.37 |
| 2025-09-30 | 113,658 | +1.4% | 53,252 | 2.13 |
| 2025-09-15 | 112,111 | -24.5% | 50,930 | 2.20 |
| 2025-08-29 | 148,493 | -2.3% | 150,332 | 1.00 |
| 2025-08-15 | 152,050 | -2.2% | 25,970 | 5.85 |
| 2025-07-31 | 155,518 | -9.2% | 90,381 | 1.72 |
| 2025-07-15 | 171,252 | -15.8% | 114,010 | 1.50 |
| 2025-06-30 | 203,501 | -22.2% | 99,336 | 2.05 |
| 2025-06-13 | 261,435 | +84.4% | 409,870 | 1.00 |
| 2025-05-30 | 141,777 | -13.2% | 24,460 | 5.80 |
| 2025-05-15 | 163,297 | -5.4% | 29,123 | 5.61 |
| 2025-04-30 | 172,692 | -16.8% | 26,289 | 6.57 |
| 2025-04-15 | 207,479 | -37.1% | 38,889 | 5.34 |
| 2025-03-31 | 329,694 | -18.6% | 49,327 | 6.68 |
| 2025-03-14 | 405,160 | -43.4% | 70,347 | 5.76 |
| 2025-02-28 | 715,906 | +205.9% | 2,274,759 | 1.00 |
| 2025-02-14 | 234,048 | -0.7% | 72,239 | 3.24 |
| 2025-01-31 | 235,593 | +80.9% | 86,922 | 2.71 |
| 2025-01-15 | 130,205 | +19.4% | 54,796 | 2.38 |
| 2024-12-31 | 109,014 | -28.9% | 37,200 | 2.93 |
| 2024-12-13 | 153,381 | +129.4% | 171,370 | 1.00 |
| 2024-11-29 | 66,859 | -10.2% | 24,133 | 2.77 |
| 2024-11-15 | 74,437 | +68.3% | 38,911 | 1.91 |
| 2024-10-31 | 44,238 | -4.3% | 23,376 | 1.89 |
| 2024-10-15 | 46,226 | -8.1% | 10,519 | 4.39 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of BRTX volume is 52.9%, down 1.8 points over the last five sessions. Over the last 30 readings it ranged from 6.4% (21 September 2026) to 83.9% (22 October 2026). The latest reading is 15.8 points above the 30-session average of 37.1%, on 25K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 13K | 25K | 52.9% | 0 |
| 2026-10-22 | 2K | 2K | 83.9% | 0 |
| 2026-10-21 | 2K | 7K | 29.5% | 856 |
| 2026-10-20 | 983 | 13K | 7.5% | 0 |
| 2026-10-19 | 4K | 9K | 50.5% | 0 |
| 2026-10-16 | 8K | 15K | 54.7% | 4,670 |
| 2026-10-15 | 11K | 17K | 65.7% | 5,281 |
| 2026-10-14 | 3K | 7K | 50.0% | 115 |
| 2026-10-13 | 13K | 20K | 64.5% | 520 |
| 2026-10-12 | 5K | 9K | 60.1% | 0 |
| 2026-10-09 | 5K | 11K | 44.1% | 103 |
| 2026-10-08 | 15K | 79K | 19.3% | 2,587 |
| 2026-10-07 | 5K | 16K | 34.1% | 0 |
| 2026-10-06 | 17K | 36K | 46.7% | 1 |
| 2026-10-05 | 10K | 42K | 23.3% | 0 |
| 2026-10-02 | 5K | 16K | 33.6% | 0 |
| 2026-10-01 | 3K | 9K | 38.5% | 0 |
| 2026-09-30 | 4K | 11K | 35.2% | 0 |
| 2026-09-29 | 3K | 7K | 39.5% | 0 |
| 2026-09-28 | 7K | 27K | 27.1% | 0 |
| 2026-09-25 | 3K | 12K | 29.0% | 10 |
| 2026-09-24 | 4K | 11K | 39.5% | 53 |
| 2026-09-23 | 7K | 23K | 28.2% | 0 |
| 2026-09-22 | 5K | 50K | 9.0% | 0 |
| 2026-09-21 | 471 | 7K | 6.4% | 0 |
| 2026-09-18 | 2K | 10K | 22.2% | 0 |
| 2026-09-17 | 450 | 7K | 6.5% | 0 |
| 2026-09-16 | 2K | 6K | 35.3% | 0 |
| 2026-09-15 | 644 | 2K | 26.5% | 0 |
| 2026-09-14 | 1K | 3K | 49.1% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in BRTX is 553 shares, down 1,409 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (10 June 2026) to 36,755 shares (16 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 553 | $2.33 | $1K |
| 2026-09-25 | 1,962 | $2.58 | $5K |
| 2026-09-24 | 83 | $2.60 | $216 |
| 2026-09-23 | 621 | $2.63 | $2K |
| 2026-09-22 | 2 | $2.71 | $5 |
| 2026-09-21 | 95 | $2.69 | $256 |
| 2026-09-18 | 58 | $2.66 | $154 |
| 2026-09-17 | 77 | $2.55 | $196 |
| 2026-09-16 | 190 | $2.64 | $502 |
| 2026-09-15 | 128 | $2.70 | $346 |
| 2026-09-14 | 1,046 | $2.67 | $3K |
| 2026-09-11 | 4,667 | $2.76 | $13K |
| 2026-09-10 | 1,613 | $2.74 | $4K |
| 2026-09-09 | 693 | $2.76 | $2K |
| 2026-09-04 | 26,810 | $0.14 | $4K |
| 2026-09-01 | 5,695 | $0.20 | $1K |
| 2026-08-31 | 8,416 | $0.20 | $2K |
| 2026-07-23 | 42 | $0.32 | $13 |
| 2026-07-08 | 721 | $0.37 | $267 |
| 2026-07-07 | 72 | $0.40 | $29 |
| 2026-07-06 | 4,160 | $0.40 | $2K |
| 2026-07-01 | 329 | $0.38 | $125 |
| 2026-06-30 | 19,864 | $0.37 | $7K |
| 2026-06-29 | 836 | $0.37 | $309 |
| 2026-06-24 | 32,154 | $0.38 | $12K |
| 2026-06-22 | 9,539 | $0.41 | $4K |
| 2026-06-18 | 31,784 | $0.40 | $13K |
| 2026-06-16 | 36,755 | $0.39 | $14K |
| 2026-06-10 | 1 | $0.39 | $0 |
| 2026-06-09 | 8,681 | $0.36 | $3K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BRTX in the last 90 days. The most recent filings are listed below. Latest filing: Silva Francisco (VP of Research and Development) on 2025-10-06.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2025-10-06 | Silva Francisco | VP of Research and Development | Grant | 12K | $1.60 | $19K | 171K |
| 2025-10-06 | ALSTODT LANCE | President, CEO, COB | Grant | 16K | $1.60 | $25K | 187K |
| 2024-10-28 | Broadrick Dale | TenPercentOwner | Sell | 1K | $1.58 | $2K | 446K |
| 2024-04-09 | Silva Francisco | VP of Research and Development | Buy | 7K | $1.25 | $8K | 156K |
| 2024-04-08 | Silva Francisco | VP of Research and Development | Buy | 476 | $1.13 | $538 | 148K |
| 2024-04-08 | Silva Francisco | VP of Research and Development | Buy | 1K | $1.17 | $1K | 149K |
| 2024-03-18 | ALSTODT LANCE | President, CEO, COB | Tax withholding | 18K | $1.39 | $25K | 172K |
| 2024-03-18 | Silva Francisco | VP of Research and Development | Tax withholding | 17K | $1.39 | $24K | 147K |
| 2024-02-09 | Broadrick Dale | TenPercentOwner | Buy | 86K | $1.32 | $114K | 478K |
| 2024-02-08 | Broadrick Dale | TenPercentOwner | Buy | 84K | $1.34 | $112K | 447K |
| 2024-02-08 | Broadrick Dale | TenPercentOwner | Buy | 74K | $1.25 | $92K | 392K |
| 2024-02-07 | Broadrick Dale | TenPercentOwner | Buy | 36K | $1.38 | $50K | 363K |
| 2023-12-01 | Broadrick Dale | TenPercentOwner | Sell | 250 | $1.88 | $470 | 327K |
| 2023-11-27 | Broadrick Dale | TenPercentOwner | Sell | 278 | $1.89 | $525 | 327K |
| 2023-09-15 | ALSTODT LANCE | President, CEO, COB | Buy | 2K | $1.70 | $4K | 190K |
| 2023-09-15 | Broadrick Dale | TenPercentOwner | Buy | 10K | $1.66 | $17K | 328K |
| 2023-09-14 | Broadrick Dale | TenPercentOwner | Buy | 10K | $1.54 | $15K | 318K |
| 2023-09-13 | ALSTODT LANCE | President, CEO, COB | Buy | 800 | $1.53 | $1K | 188K |
| 2023-09-07 | Broadrick Dale | 10% owner | Buy | 1K | $1.91 | $2K | 318K |
| 2023-09-07 | Broadrick Dale | TenPercentOwner | Buy | 1K | $1.81 | $2K | 308K |
| 2023-09-06 | ALSTODT LANCE | President, CEO, COB | Buy | 3K | $1.96 | $6K | 187K |
| 2023-08-31 | Silva Francisco | VP of Research and Development | Buy | 5K | $2.22 | $11K | 165K |
| 2023-07-28 | Broadrick Dale | TenPercentOwner | Buy | 500 | $2.89 | $1K | 307K |
| 2023-07-27 | Broadrick Dale | TenPercentOwner | Buy | 1K | $2.80 | $3K | 306K |
| 2023-07-25 | ALSTODT LANCE | President, CEO, COB | Buy | 4K | $2.44 | $10K | 184K |
| 2023-03-31 | Silva Francisco | VP of Research and Development | Buy | 747 | $3.56 | $3K | 160K |
| 2023-03-20 | ALSTODT LANCE | President, CEO, COB | Tax withholding | 7K | $2.92 | $20K | 180K |
| 2023-03-20 | Silva Francisco | VP of Research and Development | Tax withholding | 7K | $2.92 | $20K | 159K |
| 2023-02-22 | Broadrick Dale | TenPercentOwner | Buy | 5K | $2.84 | $14K | 304K |
| 2023-02-22 | Broadrick Dale | TenPercentOwner | Buy | 1K | $2.95 | $3K | 305K |
| 2023-02-18 | ALSTODT LANCE | President, CEO, COB | Tax withholding | 374 | $2.99 | $1K | 187K |
| 2023-02-18 | Silva Francisco | VP of Research and Development | Tax withholding | 374 | $2.99 | $1K | 166K |
| 2023-02-01 | ALSTODT LANCE | President, CEO, COB | Buy | 400 | $3.10 | $1K | 187K |
| 2023-01-27 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.01 | $602 | 187K |
| 2023-01-20 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.17 | $317 | 187K |
| 2023-01-20 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.10 | $310 | 187K |
| 2023-01-18 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.10 | $310 | 186K |
| 2023-01-18 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.13 | $626 | 186K |
| 2023-01-18 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.09 | $309 | 187K |
| 2023-01-09 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.08 | $308 | 186K |
| 2022-12-23 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.02 | $604 | 186K |
| 2022-12-23 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $2.99 | $299 | 186K |
| 2022-12-07 | ALSTODT LANCE | President, CEO, COB | Buy | 2K | $2.99 | $5K | 186K |
| 2022-11-30 | Broadrick Dale | 10% owner | Buy | 100 | $2.78 | $278 | 299K |
| 2022-11-30 | Broadrick Dale | TenPercentOwner | Buy | 100 | $2.77 | $277 | 299K |
| 2022-11-21 | Silva Francisco | VP of Research and Development | Buy | 943 | $2.62 | $2K | 166K |
| 2022-11-18 | ALSTODT LANCE | President, CEO, COB | Buy | 1K | $2.88 | $3K | 184K |
| 2022-10-12 | Silva Francisco | VP of Research and Development | Buy | 725 | $3.39 | $2K | 165K |
| 2022-10-11 | Silva Francisco | VP of Research and Development | Buy | 806 | $3.69 | $3K | 164K |
| 2022-09-23 | Broadrick Dale | TenPercentOwner | Buy | 300 | $2.83 | $849 | 299K |
| 2022-09-22 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $2.85 | $285 | 183K |
| 2022-09-22 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $2.99 | $299 | 183K |
| 2022-08-29 | Silva Francisco | VP of Research and Development | Buy | 3K | $3.21 | $9K | 164K |
| 2022-08-29 | Silva Francisco | VP of Research and Development | Buy | 307 | $3.32 | $1K | 12K |
| 2022-08-26 | Silva Francisco | VP of Research and Development | Buy | 3K | $3.35 | $9K | 161K |
| 2022-08-26 | Silva Francisco | VP of Research and Development | Sell | 4K | $3.39 | $13K | 158K |
| 2022-07-13 | Broadrick Dale | TenPercentOwner | Buy | 200 | $3.00 | $600 | 299K |
| 2022-07-12 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $2.95 | $2K | 183K |
| 2022-07-12 | Broadrick Dale | TenPercentOwner | Buy | 900 | $2.97 | $3K | 298K |
| 2022-07-06 | Broadrick Dale | TenPercentOwner | Buy | 100 | $3.38 | $338 | 297K |
| 2022-06-30 | ALSTODT LANCE | President, CEO, COB | Buy | 1K | $3.10 | $3K | 182K |
| 2022-06-30 | Broadrick Dale | TenPercentOwner | Buy | 2K | $3.08 | $6K | 297K |
| 2022-06-21 | Broadrick Dale | TenPercentOwner | Buy | 100 | $3.68 | $368 | 295K |
| 2022-06-17 | Broadrick Dale | TenPercentOwner | Buy | 600 | $3.80 | $2K | 295K |
| 2022-06-16 | ALSTODT LANCE | President, CEO, COB | Buy | 600 | $3.73 | $2K | 181K |
| 2022-06-16 | Broadrick Dale | TenPercentOwner | Buy | 2K | $3.81 | $8K | 295K |
| 2022-06-15 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $3.68 | $3K | 180K |
| 2022-06-15 | Kristal Robert Eugene | Chief Financial Officer | Buy | 194 | $3.61 | $700 | 8K |
| 2022-06-15 | Broadrick Dale | TenPercentOwner | Buy | 1K | $3.72 | $4K | 293K |
| 2022-06-14 | ALSTODT LANCE | President, CEO, COB | Buy | 500 | $3.91 | $2K | 180K |
| 2022-06-14 | Silva Francisco | VP of Research and Development | Grant | 263 | $3.78 | $994 | 162K |
| 2022-06-13 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.98 | $398 | 179K |
| 2022-06-13 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.92 | $392 | 179K |
| 2022-06-13 | Broadrick Dale | TenPercentOwner | Buy | 1K | $3.92 | $5K | 292K |
| 2022-06-10 | Broadrick Dale | TenPercentOwner | Buy | 600 | $4.23 | $3K | 290K |
| 2022-06-09 | Broadrick Dale | TenPercentOwner | Buy | 1K | $4.27 | $4K | 290K |
| 2022-06-08 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $4.28 | $428 | 179K |
| 2022-06-08 | Broadrick Dale | TenPercentOwner | Buy | 2K | $4.33 | $10K | 289K |
| 2022-06-07 | Kristal Robert Eugene | Chief Financial Officer | Buy | 200 | $4.56 | $912 | 8K |
| 2022-06-07 | Silva Francisco | VP of Research and Development | Grant | 565 | $4.65 | $3K | 162K |
| 2022-06-07 | Broadrick Dale | TenPercentOwner | Buy | 4K | $4.72 | $17K | 286K |
| 2022-06-06 | Broadrick Dale | TenPercentOwner | Buy | 3K | $4.93 | $15K | 283K |
| 2022-06-03 | Broadrick Dale | TenPercentOwner | Buy | 1K | $4.90 | $6K | 280K |
| 2022-06-02 | Broadrick Dale | TenPercentOwner | Buy | 1K | $4.69 | $5K | 278K |
| 2022-06-01 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $4.60 | $920 | 179K |
| 2022-06-01 | Broadrick Dale | TenPercentOwner | Buy | 9K | $4.46 | $41K | 277K |
| 2022-05-27 | Broadrick Dale | TenPercentOwner | Buy | 11K | $3.61 | $40K | 268K |
| 2022-05-26 | ALSTODT LANCE | President, CEO, COB | Buy | 3K | $3.52 | $10K | 179K |
| 2022-05-26 | Broadrick Dale | TenPercentOwner | Buy | 5K | $3.51 | $17K | 259K |
| 2022-05-26 | Broadrick Dale | TenPercentOwner | Sell | 2K | $3.44 | $7K | 257K |
| 2022-05-02 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.96 | $792 | 176K |
| 2022-05-02 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.94 | $788 | 176K |
| 2022-04-08 | Kristal Robert Eugene | Chief Financial Officer | Buy | 8K | $5.71 | $43K | 8K |
| 2022-04-06 | Broadrick Dale | TenPercentOwner | Buy | 3K | $5.66 | $14K | 254K |
| 2022-04-05 | Broadrick Dale | TenPercentOwner | Buy | 30K | $5.64 | $169K | 252K |
| 2022-04-05 | Broadrick Dale | TenPercentOwner | Buy | 16K | $5.84 | $93K | 222K |
| 2022-03-31 | Broadrick Dale | TenPercentOwner | Buy | 10K | $4.71 | $47K | 316K |
| 2022-03-31 | Broadrick Dale | TenPercentOwner | Buy | 700 | $4.84 | $3K | 317K |
| 2022-03-29 | Broadrick Dale | TenPercentOwner | Buy | 5K | $5.12 | $26K | 306K |
| 2022-03-21 | Broadrick Dale | TenPercentOwner | Buy | 10K | $4.35 | $44K | 206K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of BRTX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Auctus Fund, LLC at 9.9% of the class (2,699,470 shares), filed 2026-05-15 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-03 | 13G/Ano. 1 | Alta Partners LLCother entity | 1.3M | 4.9% | 2026-02-13 |
| 2026-05-15 | 13G/Ano. 7 | Auctus Fund, LLCpartnership | 2.7M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Auctus Fund Management LLCinvestment adviser, parent holding company, other entity | 2.7M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Alfred Sollamiindividual, parent holding company | 2.7M | 9.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Louis Posnerindividual, parent holding company | 2.7M | 9.9% | 2026-03-31 |
| 2026-02-23 | 13G/Ano. 8 | Morrison Todd Haleindividual | 0 | 0.0% | 2026-02-23 |
| 2026-02-18 | 13G | Mitchell P. Kopinparent holding company, individual | 922K | 4.1% | 2026-02-11 |
| 2026-02-18 | 13G | Daniel B. Asherparent holding company, individual | 922K | 4.1% | 2026-02-11 |
| 2026-02-18 | 13G | INTRACOASTAL CAPITAL, LLCother entity | 922K | 4.1% | 2026-02-11 |
13F holders
Tracked managers holding BRTX at their latest 13F. JSON1 of the 30 tracked managers held BRTX at their latest 13F, $103K in total at quarter-end prices. Citadel Advisors is the largest at $103K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 273K | $103K | 0.00% | +35K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
BioRestorative Therapies in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows BioRestorative Therapies (BRTX), SEC CIK 1505497, listed on Nasdaq, classified by the SEC as services-misc health & allied services, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-03.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-10-06.JSON and CSV
- Company record
- EDGAR filing index for CIK 1505497Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-misc health & allied services, nec
Other company pages
Datasets
Frequently Asked Questions
How much of BRTX is sold short?
13,152 shares were held short at the 2026-09-30 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BRTX's daily short volume?
On 2026-10-23, 13,365 of the 25,248 BRTX shares reported to FINRA were sold short, 52.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BRTX have fails to deliver?
The SEC's latest file shows 553 BRTX shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are BRTX insiders buying or selling?
No open-market insider trades were reported for BRTX in the last 90 days. The most recent filings are listed below. Latest filing: Silva Francisco (VP of Research and Development) on 2025-10-06.
Who owns 5% or more of BRTX?
4 holders report 5% or more of BRTX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Auctus Fund, LLC at 9.9% of the class (2,699,470 shares), filed 2026-05-15 for an event on 2026-03-31.
Which tracked 13F managers own BRTX?
1 of the 30 tracked 13F managers held BRTX shares at their latest filing, $103K in all. The largest: Ken Griffin's Citadel Advisors (273K shares, $103K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.